SCHEMBL18239979

SCHEMBL18239979

Cc1nc(OC[C@]2(C(C)(C)C)CN(C(=O)O)CCO2)sc1S(=O)(=O)NC(=O)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CC(C)(C)CC3)CC2)cc1Oc1cccc2[nH]ncc12

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 6/20 0.79
▸ BCL2L1 Q07817 6/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18240011 0.92 BCL2 (0.79) BCL2BCL2L1
SCHEMBL1743243 0.88 BCL2 (0.89) BCL2BCL2L1
SCHEMBL1743443 0.88 BCL2 (1.00) BCL2BCL2L1
SCHEMBL1743246 0.86 BCL2 (1.00) BCL2BCL2L1
SCHEMBL2798924 0.86 BCL2 (1.00) BCL2BCL2L1
SCHEMBL1745756 0.80 BCL2 (0.89) BCL2BCL2L1
SCHEMBL1744369 0.80 BCL2 (1.00) BCL2BCL2L1
SCHEMBL19424991 0.79 — —
SCHEMBL18240009 0.78 BCL2 (1.00) BCL2BCL2L1
SCHEMBL19424988 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3095784-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES AbbVie Inc. (US) 2016-11-23 — — EP disclosed
Send feedback